Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
0.691
-0.009 (-1.29%)
At close: Apr 28, 2026, 4:00 PM EDT
0.703
+0.012 (1.72%)
Pre-market: Apr 29, 2026, 8:00 AM EDT
Tenaya Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 150 | 154 | 113 | 221 | 129 | 782 | |
| Market Cap Growth | 88.32% | 35.98% | -48.67% | 71.58% | -83.56% | - | |
| Enterprise Value | 60 | 109 | 48 | 105 | -5 | 518 | |
| Last Close Price | 0.69 | 0.71 | 1.43 | 3.24 | 2.01 | 18.95 | |
| PB Ratio | 1.22 | 1.25 | 1.22 | 1.58 | 0.53 | 2.81 | |
| P/TBV Ratio | 1.22 | 1.25 | 1.22 | 1.58 | 0.53 | 2.81 | |
| Debt / Equity Ratio | 0.09 | 0.09 | 0.15 | 0.09 | 0.06 | 0.06 | |
| Net Debt / Equity Ratio | -0.73 | -0.73 | -0.51 | -0.66 | -0.78 | -0.85 | |
| Net Debt / EBITDA Ratio | 1.06 | 1.06 | 0.45 | 0.75 | 1.59 | 3.37 | |
| Net Debt / FCF Ratio | 1.30 | 1.30 | 0.52 | 0.89 | 1.51 | 2.74 | |
| Quick Ratio | 6.51 | 6.51 | 3.85 | 4.60 | 7.79 | 11.54 | |
| Current Ratio | 6.84 | 6.84 | 4.22 | 4.91 | 7.99 | 11.73 | |
| Return on Equity (ROE) | -83.84% | -83.84% | -95.69% | -64.83% | -47.39% | -34.80% | |
| Return on Assets (ROA) | -43.72% | -43.72% | -49.90% | -36.49% | -26.47% | -19.68% | |
| Return on Capital Employed (ROCE) | -71.00% | -71.00% | -111.50% | -88.80% | -49.30% | -24.90% | |
| Earnings Yield | -60.42% | -58.81% | -98.10% | -56.23% | -96.15% | -9.30% | |
| FCF Yield | -45.94% | -44.72% | -80.79% | -46.81% | -97.23% | -10.98% | |
| Buyback Yield / Dilution | -80.34% | -80.34% | -14.96% | -64.61% | -152.75% | -1724.33% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.